This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
style-scores: Archive
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CVSNegative Net Change LHNegative Net Change
earnings-surprise price-change style-scores valuation
Avino Silver (ASM) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Avino Silver (ASM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ASMNegative Net Change BVNNegative Net Change
earnings-surprise price-change style-scores valuation
FirstCash Holdings, Inc. (FCFS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
FirstCash (FCFS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
FCFSPositive Net Change
earnings-surprise price-change style-scores valuation
Copa Holdings, S.A. (CPA) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Copa Holdings (CPA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CPAPositive Net Change ICAGYPositive Net Change
earnings-surprise price-change style-scores valuation
International Consolidated Airlines Group SA (ICAGY) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
International Consolidated Airlines Group (ICAGY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICAGYPositive Net Change
earnings-surprise price-change style-scores valuation
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Supernus (SUPN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SUPNPositive Net Change
earnings-surprise price-change style-scores valuation
Grupo Cibest S.A. - Sponsored ADR (CIB) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Grupo Cibest (CIB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CIBPositive Net Change
earnings-surprise price-change style-scores valuation
Amphenol Corporation (APH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Amphenol (APH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
APHPositive Net Change
earnings-surprise price-change style-scores valuation
BWX Technologies, Inc. (BWXT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
BWX (BWXT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWXTPositive Net Change ATIPositive Net Change
earnings-surprise price-change style-scores valuation
Black Diamond Therapeutics, Inc. (BDTX) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Black Diamond (BDTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BDTXPositive Net Change EXASPositive Net Change
earnings-surprise price-change style-scores valuation